- Home
- MYFW vs INBX Comparison
MYFW vs INBX Comparison
Compare MYFW & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- INBX
- Stock Information
- Founded
- MYFW 2002
- INBX 2010
- Country
- MYFW United States
- INBX United States
- Employees
- MYFW N/A
- INBX N/A
- Industry
- MYFW Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- INBX Health Care
- Exchange
- MYFW Nasdaq
- INBX Nasdaq
- Market Cap
- MYFW 184.7M
- INBX 218.9M
- IPO Year
- MYFW 2018
- INBX 2020
- Fundamental
- Price
- MYFW $17.68
- INBX $12.74
- Analyst Decision
- MYFW Buy
- INBX Hold
- Analyst Count
- MYFW 3
- INBX 1
- Target Price
- MYFW $22.33
- INBX N/A
- AVG Volume (30 Days)
- MYFW 19.9K
- INBX 74.4K
- Earning Date
- MYFW 01-23-2025
- INBX 11-14-2024
- Dividend Yield
- MYFW N/A
- INBX N/A
- EPS Growth
- MYFW N/A
- INBX N/A
- EPS
- MYFW 0.26
- INBX 119.38
- Revenue
- MYFW $79,649,000.00
- INBX $1,568,000.00
- Revenue This Year
- MYFW N/A
- INBX N/A
- Revenue Next Year
- MYFW $12.86
- INBX N/A
- P/E Ratio
- MYFW $68.15
- INBX $0.11
- Revenue Growth
- MYFW N/A
- INBX 19.24
- 52 Week Low
- MYFW $12.84
- INBX $10.80
- 52 Week High
- MYFW $22.32
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- MYFW 27.46
- INBX 32.23
- Support Level
- MYFW $17.10
- INBX $13.57
- Resistance Level
- MYFW $19.41
- INBX $16.83
- Average True Range (ATR)
- MYFW 0.66
- INBX 0.94
- MACD
- MYFW -0.18
- INBX -0.21
- Stochastic Oscillator
- MYFW 20.49
- INBX 1.68
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.